Clinical Trials in San Diego

Showing 3461-3480 of 7,028 trials

Blood Flow Restriction Exercise in the Treatment of Lateral Epicondylalgia Traditional Treatment

NCT04607356

The purpose of this study is to compare the clinical effectiveness and outcomes between current evidence based clinical care and use of personalized blood flow restriction training in the treatment of lateral epicondylalgia ("tennis elbow").

Tennis ElbowLateral Epicondylitis

United States Naval Medical Center, San Diego104 participantsStarted Mar 2021

San Diego, California, United States

COMPLETEDPhase 3< 1 mile

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

NCT00326898

This randomized phase III trial studies sunitinib malate to see how well it works compared to sorafenib tosylate or placebo in treating patients with kidney cancer that has been removed by surgery. Sunitinib malate and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sunitinib malate or sorafenib tosylate after surgery may kill any tumor cells that remain after surgery. It is not yet known whether sunitinib malate is more effective than sorafenib tosylate or placebo in treating kidney cancer.

Clear Cell Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7Stage II Renal Cell Cancer AJCC v7+1 more

National Cancer Institute (NCI)1,943 participantsStarted Apr 2006

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +984 more locations

Blood Flow Restriction Exercise in the Treatment of Lateral Epicondylalgia Traditional Treatment

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Find Trials by Condition in San Diego

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Study of TV-1106 in Growth Hormone-Deficient Adults

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

Safety Study of MGA271 in Refractory Cancer

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma